Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Value of Local Therapies in Advanced Adrenocortical Carcinoma.
Kimpel O, Altieri B, Laganà M, Vogl TJ, Adwan H, Dusek T, Basile V, Pittaway J, Dischinger U, Quinkler M, Kroiss M, Puglisi S, Cosentini D, Kickuth R, Kastelan D, Fassnacht M. Kimpel O, et al. Among authors: kickuth r. Cancers (Basel). 2024 Feb 7;16(4):706. doi: 10.3390/cancers16040706. Cancers (Basel). 2024. PMID: 38398097 Free PMC article.
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study.
Detomas M, Ritzel K, Nasi-Kordhishti I, Schernthaner-Reiter MH, Losa M, Tröger V, Altieri B, Kroiss M, Kickuth R, Fassnacht M, Micko A, Honegger J, Reincke M, Deutschbein T. Detomas M, et al. Among authors: kickuth r. Eur J Endocrinol. 2023 May 18:lvad050. doi: 10.1093/ejendo/lvad050. Online ahead of print. Eur J Endocrinol. 2023. PMID: 37200460
Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma.
Kimpel O, Dischinger U, Altieri B, Fuss CT, Polat B, Kickuth R, Kroiss M, Fassnacht M. Kimpel O, et al. Among authors: kickuth r. Horm Metab Res. 2024 Jan;56(1):91-98. doi: 10.1055/a-2209-6022. Epub 2024 Jan 3. Horm Metab Res. 2024. PMID: 38171374 Free PMC article. Review.
Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations.
Reiter FP, Rau M, Kunzmann V, Kickuth R, Klein I, Neumann O, Stenzinger A, Schirmacher P, Geier A. Reiter FP, et al. Among authors: kickuth r. Z Gastroenterol. 2023 Jan;61(1):71-75. doi: 10.1055/a-1952-1233. Epub 2022 Nov 15. Z Gastroenterol. 2023. PMID: 36379463 English.
145 results